Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F

Blood

Volumn 113, Issue 9, 2009, Pages 2022-2027

  Schaub, Franz X ^a   Jäger, Roland ^b   Looser, Renate ^a   Hao Shen, Hui ^a   Hermouet, Sylvie ^c,d   Girodon, François ^e   Tichelli, Andre ^a   Gisslinger, Heinz ^f   Kralovics, Robert ^b,f   Skoda, Radek C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c INSTITUT DE BIOLOGIE   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANAGRELIDE; HYDROXYUREA; INTERFERON; JANUS KINASE 2; LENALIDOMIDE; METHYLCELLULOSE;

ABORTION; ADULT; AGED; ANALYSIS; ANEMIA; ARTERY DISEASE; ARTICLE; BLEEDING; BLOOD; BURST FORMING UNIT E; CHROMOSOME 20Q; CHROMOSOME DELETION; CLONE; COLONY FORMING UNIT; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENOTYPE; GRANULOCYTE; HEART INFARCTION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PARENT; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCREENING; SPLENOMEGALY; THROMBOCYTHEMIA; TRANSIENT ISCHEMIC ATTACK; WILD TYPE;

EID: 61849118935     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-07-167056     Document Type: Article

References (26)

1. Rege-Cambrin G, Mecucci C, Tricot G, et al. A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet. 1987;25:233-245.
2. Demory JL, Dupriez B, Fenaux P, et al. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood. 1988;72:855-859.
3. Diez-Martin JL, Graham DL, Petitt RM, Dewald GW. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc. 1991;66:287-299.
4. Mertens F, Johansson B, Heim S, Kristoffersson U, Mitelman F. Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia. 1991;5:214-220.
5. Asimakopoulos FA, White NJ, Nacheva E, Green AR. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood. 1994;84: 3086-3094.
6. Asimakopoulos FA, Gilbert JG, Aldred MA, Pearson TC, Green AR. Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera. Blood. 1996;88:2690-2698.
7. Bench AJ, Aldred MA, Humphray SJ, et al. A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region. Genomics. 1998;49:351-362.
8. Bench AJ, Nacheva EP, Champion KM, Green AR. Molecular genetics and cytogenetics of myeloproliferative disorders. Baillieres Clin Haematol. 1998;11:819-848.
9. Bench AJ, Nacheva EP, Hood TL, et al. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene. 2000;19:3902-3913.
10. Douet-Guilbert N, Basinko A, Morel F, et al. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions. Ann Hematol. 2008;87:537-544.
11. Li J, Bench AJ, Vassiliou GS, Fourouclas N, Ferguson-Smith AC, Green AR. Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies. Proc Natl Acad Sci U S A. 2004;101:7341-7346.
12. Gangat N, Strand J, Lasho TL, et al. Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates. Eur J Haematol. 2008;80:197-200.
13. Campbell PJ, Baxter EJ, Beer PA, et al. Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation. Blood. 2006; 108:3548-3555.
14. Kralovics R, Teo SS, Li S, et al. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood. 2006;108:1377-1380.
15. Kralovics R, Buser AS, Teo SS, et al. Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood. 2003; 102:1869-1871.
16. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779-1790.
17. Li S, Kralovics R, De Libero G, Theocharides A, Gisslinger H, Skoda RC. Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations. Blood. 2008;111: 3863-3866.
18. Liva S, Hupe P, Neuvial P, et al. CAPweb: a bioinformatics CGH array Analysis Platform. Nucleic Acids Res. 2006;34:W477-W481.
19. Levine RL, Belisle C, Wadleigh M, et al. X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/ MMM, and identifies a subset of JAK2V617F-nega-tive ET and MMM patients with clonal hematopoiesis. Blood. 2006;107:4139-4141.
20. Nussenzveig RH, Swierczek SI, Jelinek J, et al. Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol. 2007;35:32-38.
21. Pardanani A, Lasho TL, Finke C, et al. Extending Jak2V617F and MplW515 mutation analysis to single hematopoietic colonies and B and T lymphocytes. Stem Cells. 2007;25:2358-2362.
22. Pardanani AD, Levine RL, Lasho T, et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood. 2006; 108:3472-3476.
23. Lasho TL, Pardanani A, McClure RF, et al. Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time. Br J Haematol. 2006;135:683-687.
24. Greenman C, Stephens P, Smith R, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446:153-158.
25. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colo-rectal cancers. Science. 2006;314:268-274.
26. Plo I, Nakatake M, Malivert L, et al. JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. Blood. 2008;112:1402-1412.